Cargando…

Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study)

INTRODUCTION: From 2018 single inhaler triple therapy (SITT) became available in France to treat moderate-to-severe chronic obstructive pulmonary disease (COPD). Given its simplified inhaler use compared with multiple inhaler triple therapy (MITT), this therapeutic option has the potential to offer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deslee, Gaétan, Fabry-Vendrand, Caroline, Poccardi, Nolwenn, Thabut, Gabriel, Eteve Pitsaer, Caroline, Coriat, Adrien, Renaudat, Charlotte, Maguire, Andrew, Pinto, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Respiratory Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255131/ https://www.ncbi.nlm.nih.gov/pubmed/37263738 http://dx.doi.org/10.1136/bmjresp-2022-001585

Ejemplares similares

Characteristics of patients with severe, uncontrolled, eosinophilic asthma enrolled in a French cohort
por: Aubier, Michel, et al.
Publicado: (2018)

Time trends in the incidence of essential tremor: Evidences from UK and France primary care data
por: Antonazzo, Ippazio Cosimo, et al.
Publicado: (2022)

Characteristics of Severe Non-Eosinophilic Asthma: Analysis of Data from 1075 Patients Included in the FASE-CPHG Study
por: Portel, Laurent, et al.
Publicado: (2023)

Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus study
por: Suehs, Carey Meredith, et al.
Publicado: (2020)

PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population
por: Criner, Gerard, et al.
Publicado: (2023)

Optimising treatment for COPD – new strategies for combination therapy
por: Welte, T
Publicado: (2009)

Inhaler technique education in elderly patients with asthma or COPD: impact on disease exacerbations—a protocol for a single-blinded randomised controlled trial
por: Maricoto, Tiago, et al.
Publicado: (2019)

Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial
por: Lötvall, J, et al.
Publicado: (2012)

Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting β(2)-agonists in obstructive lung diseases: a population-based, observational study
por: Björnsdóttir, U S, et al.
Publicado: (2014)

Protocol for a human in vivo model of acute cigarette smoke inhalation challenge in smokers with COPD: monitoring the nasal and systemic immune response using a network biology approach
por: Ross, Clare L, et al.
Publicado: (2015)

A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting β(2)-agonists for asthma maintenance treatment in Germany
por: Aballéa, S, et al.
Publicado: (2008)

Preventing adverse cardiac events (PACE) in chronic obstructive pulmonary disease (COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of bisoprolol in COPD
por: Martin, Allison, et al.
Publicado: (2021)

Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap
por: Ingebrigtsen, Truls Sylvan, et al.
Publicado: (2020)

Impact of COPD case finding on clinical care: a prospective analysis of the TargetCOPD trial
por: Haroon, Shamil, et al.
Publicado: (2020)

The boundaries of mild chronic obstructive pulmonary disease (COPD): design of the searching clinical COPD onset (SOON) study
por: Labarca, Gonzalo, et al.
Publicado: (2017)

Rat model of smoke inhalation-induced acute lung injury
por: Leiphrakpam, Premila Devi, et al.
Publicado: (2021)

Lung volume reduction eligibility in patients with COPD completing pulmonary rehabilitation: results from the UK National Asthma and COPD Audit Programme
por: Buttery, Sara C, et al.
Publicado: (2020)

Assessing the impact of COVID-19 measures on COPD management and patients: a simulation-based decision support tool for COPD services in the UK
por: Yakutcan, Usame, et al.
Publicado: (2022)

AZD7442 utilization for Pre-Exposure Prophylaxis Against COVID-19 in a French Early Access Program
por: Artaud, C, et al.
Publicado: (2023)

Evaluation of inhaler handling-errors, inhaler perception and preference with Spiromax, Easyhaler and Turbuhaler devices among healthy Finnish volunteers: a single site, single visit crossover study (Finhaler)
por: Sandler, Niklas, et al.
Publicado: (2016)

Impact of cardiovascular comorbidities on COPD Assessment Test (CAT) and its responsiveness to pulmonary rehabilitation in patients with moderate to very severe COPD: protocol of the Chance study
por: Smid, Dionne E, et al.
Publicado: (2015)

Investigating fractional exhaled nitric oxide (FeNO) in chronic obstructive pulmonary disease (COPD) and asthma–COPD overlap (ACO): a scoping review protocol
por: Mostafavi-Pour-Manshadi, Seyed-Mohammad-Yousof, et al.
Publicado: (2017)

Pain in patients with COPD: a systematic review and meta-analysis
por: van Dam van Isselt, Eléonore F, et al.
Publicado: (2014)

Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study
por: Terzikhan, Natalie, et al.
Publicado: (2016)

Complications and discomfort after research bronchoscopy in the MicroCOPD study
por: Leiten, Elise Orvedal, et al.
Publicado: (2020)

Relationship between heart failure and the risk of acute exacerbation of COPD
por: Axson, Eleanor L, et al.
Publicado: (2021)

Effectiveness of the Assessment of Burden of COPD (ABC) tool on health-related quality of life in patients with COPD: a cluster randomised controlled trial in primary and hospital care
por: Slok, Annerika H M, et al.
Publicado: (2016)

Inhaled therapies for chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Axson, Eleanor L, et al.
Publicado: (2020)

Chemical exposure and alveolar macrophages responses: ‘the role of pulmonary defense mechanism in inhalation injuries’
por: Tapak, Mahtab, et al.
Publicado: (2023)

Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013)

Cost-effectiveness of integrated COPD care: the RECODE cluster randomised trial
por: Boland, Melinde R S, et al.
Publicado: (2015)

Inspiratory crackles—early and late—revisited: identifying COPD by crackle characteristics
por: Melbye, Hasse, et al.
Publicado: (2021)

Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study
por: Dalon, Faustine, et al.
Publicado: (2019)

A randomised controlled trial of small particle inhaled steroids in refractory eosinophilic asthma (SPIRA)
por: Hodgson, David, et al.
Publicado: (2015)

Perceptions of medical students towards antibiotic prescribing for upper respiratory tract infections in Saudi Arabia
por: Harakeh, Steve, et al.
Publicado: (2015)

Delayed antibiotic prescribing for respiratory tract infections: protocol of an individual patient data meta-analysis
por: Stuart, Beth, et al.
Publicado: (2019)

Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France
por: Whittaker, Hannah, et al.
Publicado: (2022)

Ten-year prediction model for post-bronchodilator airflow obstruction and early detection of COPD: development and validation in two middle-aged population-based cohorts
por: Perret, Jennifer L, et al.
Publicado: (2021)

Loss of GD1-positive Lactobacillus correlates with inflammation in human lungs with COPD
por: Sze, Marc A, et al.
Publicado: (2015)

Diagnostic accuracy of screening tests for COPD: a systematic review and meta-analysis
por: Haroon, Shamil, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_shpjgd7uqmc04a0fdnnfmmtac3